Amundi Portfolio holdings
Amundi, established in 2010 through the merger of Crédit Agricole and Société Générale’s asset management arms, is Europe’s largest asset management firm, headquartered in Paris, France, overseeing €2.2 trillion ($2.3 trillion USD) in assets as of late 2024. Serving institutional clients, financial advisors, and retail investors across 35 countries, Amundi offers a broad spectrum of investment solutions, including active and passive funds, ETFs, and sustainable investing options, with a strong focus on cost efficiency and ESG (environmental, social, governance) principles. The firm’s growth has been fueled by strategic acquisitions, such as Pioneer Investments in 2017 and Lyxor in 2021, enhancing its global reach and expertise in index tracking and alternatives. Majority-owned by Crédit Agricole, Amundi combines French financial heritage with a modern, client-centric approach, maintaining a dominant position in Europe while expanding in Asia and the Americas.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$398M |
| 2 |
Apple
AAPL
|
+$326M |
| 3 |
Vertex Pharmaceuticals
VRTX
|
+$286M |
| 4 |
UnitedHealth
UNH
|
+$267M |
| 5 |
Veralto
VLTO
|
+$265M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Wells Fargo 7.5% Non Cumv Perp Conv
WFC.PRL
|
+$730M |
| 2 |
Meta Platforms (Facebook)
META
|
+$674M |
| 3 |
Costco
COST
|
+$635M |
| 4 |
Amazon
AMZN
|
+$528M |
| 5 |
Expedia Group
EXPE
|
+$491M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 29% |
| 2 | Healthcare | 13.85% |
| 3 | Consumer Discretionary | 11.46% |
| 4 | Financials | 11.04% |
| 5 | Industrials | 7.89% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1676
Standard Motor Products
SMP
$861M
| $95.5K | ﹤0.01% |
2,469
+221
| +10% | +$7.88K |
|
1677
Methode Electronics
MEI
$543M
| $94.9K | ﹤0.01% |
4,518
-3
| -0.1% | -$70 |
|
|
CCRN
1678
DELISTED
Cross Country Healthcare
CCRN
| $94.6K | ﹤0.01% |
4,129
| – | – |
|
|
OSG
1679
Octave Specialty Group
OSG
$252M
| $93.9K | ﹤0.01% |
6,006
+33
| +0.6% | +$459 |
|
1680
Vanguard S&P 500 Value ETF
VOOV
$6.58B
| $93.4K | ﹤0.01% |
555
| – | – |
|
1681
Tower Semiconductor
TSEM
$26.4B
| $93K | ﹤0.01% |
3,092
-946
| -23% | -$24.7K |
|
1682
Advantage Solutions
ADV
$484M
| $92.9K | ﹤0.01% |
999
| – | – |
|
1683
Fulgent Genetics
FLGT
$559M
| $92.4K | ﹤0.01% |
3,231
-1,099
| -25% | -$29.4K |
|
1684
Relay Therapeutics
RLAY
$4.02B
| $92.3K | ﹤0.01% |
+7,775
| New | +$65.6K |
|
|
INVX
1685
Innovex International
INVX
$1.87B
| $90.9K | ﹤0.01% |
4,362
| – | – |
|
1686
Heritage Financial
HFWA
$1.24B
| $90.2K | ﹤0.01% |
4,461
| – | – |
|
1687
Shutterstock
SSTK
$205M
| $89.8K | ﹤0.01% |
1,860
+463
| +33% | +$19.5K |
|
|
RYZ
1688
Ryerson Holding Corp
RYZ
$1.6B
| $89.3K | ﹤0.01% |
2,784
-9,170
| -77% | -$273K |
|
1689
Resources Connection
RGP
$129M
| $89.2K | ﹤0.01% |
6,819
+381
| +6% | +$5.33K |
|
1690
Artivion
AORT
$1.23B
| $88.9K | ﹤0.01% |
4,994
| – | – |
|
1691
Nabors Industries
NBR
$1.23B
| $88.9K | ﹤0.01% |
1,161
+66
| +6% | +$6.4K |
|
|
ETWO
1692
DELISTED
E2open Parent Holdings
ETWO
| $88.3K | ﹤0.01% |
22,983
| – | – |
|
1693
Tompkins Financial
TMP
$1.45B
| $87.7K | ﹤0.01% |
1,621
-1
| -0.1% | -$54 |
|
1694
Stratasys
SSYS
$697M
| $87.4K | ﹤0.01% |
6,236
| – | – |
|
|
SHOE
1695
Shoe Station Group
SHOE
$395M
| $86.1K | ﹤0.01% |
3,169
+457
| +17% | +$11.5K |
|
1696
HealthStream
HSTM
$793M
| $85.7K | ﹤0.01% |
3,213
| – | – |
|
1697
Williams-Sonoma
WSM
$26.7B
| $85K | ﹤0.01% |
844
-57,824
| -99% | -$5.01M |
|
1698
Heartland Express
HTLD
$1.11B
| $84.5K | ﹤0.01% |
6,212
+667
| +12% | +$9.12K |
|
|
VMEO
1699
DELISTED
Vimeo
VMEO
| $84K | ﹤0.01% |
22,762
| – | – |
|
|
GES
1700
DELISTED
Guess Inc
GES
| $83.4K | ﹤0.01% |
3,659
| – | – |
|
Similar funds
Amundi's Q4 2023 Portfolio in Review
As of Q4 2023, Amundi held 2,118 positions worth $222B, up 9.2% from $203B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Amundi's Q4 2023 filing shows 107 new, 857 increased, 762 reduced and 120 closed positions. Its largest new stake was Veralto: 3,549,374 shares worth $276M. The largest sale was Wells Fargo 7.5% Non Cumv Perp Conv, an estimated $730M.
By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 28% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Amundi's largest Q4 2023 buy was Veralto: 3,549,374 shares worth $276M.
- Amundi added most to Johnson & Johnson in Q4 2023, an estimated $398M increase.
- Amundi's biggest Q4 2023 reduction was Wells Fargo 7.5% Non Cumv Perp Conv, cutting an estimated $730M.
- Amundi fully exited Activision Blizzard in Q4 2023, selling an estimated $284M.
- Amundi's ten largest holdings make up 23% of its $222B portfolio in Q4 2023.
- Amundi opened 107 new positions and closed 120 in Q4 2023.
- Amundi's portfolio value rose 9.2% quarter-over-quarter to $222B.
Based on Amundi's 13F filing for Q4 2023, filed 14 Feb 2024.